drugset / Trial / NCT03830320
Positron Emission Tomography (PET) Imaging of Thrombosis
Phase 1
Recruiting
165 enrolled
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI) · collab
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invasive alternative to the current standard-of-care methods.
Timeline
- Start
- 2016-04-01
- Primary completion
- 2027-01-31
- Completion
- 2027-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 64Cu-FBP8 | Diagnostic / imaging agent | — | — |